AU2001260727A1 - Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof - Google Patents

Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof

Info

Publication number
AU2001260727A1
AU2001260727A1 AU2001260727A AU6072701A AU2001260727A1 AU 2001260727 A1 AU2001260727 A1 AU 2001260727A1 AU 2001260727 A AU2001260727 A AU 2001260727A AU 6072701 A AU6072701 A AU 6072701A AU 2001260727 A1 AU2001260727 A1 AU 2001260727A1
Authority
AU
Australia
Prior art keywords
pranlukast
solid dispersion
dispersion system
preparing method
improved dissolution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001260727A
Other languages
English (en)
Inventor
Sang Deuk Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001260727A1 publication Critical patent/AU2001260727A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
AU2001260727A 2000-05-20 2001-05-17 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof Abandoned AU2001260727A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2000-0027237A KR100381834B1 (ko) 2000-05-20 2000-05-20 용출성이 개선된 프란루카스트 고체분산체 조성물 및 그제조 방법
KR0027237 2000-05-20
PCT/KR2001/000804 WO2001089574A1 (en) 2000-05-20 2001-05-17 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof

Publications (1)

Publication Number Publication Date
AU2001260727A1 true AU2001260727A1 (en) 2001-12-03

Family

ID=36794425

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001260727A Abandoned AU2001260727A1 (en) 2000-05-20 2001-05-17 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof

Country Status (9)

Country Link
US (1) US20030077322A1 (ko)
EP (1) EP1283725B1 (ko)
JP (1) JP3967924B2 (ko)
KR (1) KR100381834B1 (ko)
CN (1) CN1210065C (ko)
AU (1) AU2001260727A1 (ko)
CA (1) CA2405459A1 (ko)
DE (1) DE60121574T2 (ko)
WO (1) WO2001089574A1 (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10350528A1 (de) * 2003-10-29 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Arzneimittelformulierung, enthaltend einen LTB4-Antagonisten, sowie Verfahren zu deren Herstellung und deren Verwendung
JP2007511559A (ja) * 2003-11-18 2007-05-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 固形医薬製剤
JP2007536299A (ja) * 2004-05-04 2007-12-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｌｔｂ４アンタゴニトを含有する固形医薬形態
JP4742679B2 (ja) * 2004-05-27 2011-08-10 小野薬品工業株式会社 固形製剤用組成物
JP2006206612A (ja) * 2004-05-27 2006-08-10 Ono Pharmaceut Co Ltd 固形製剤用組成物
JP2007223903A (ja) * 2004-07-09 2007-09-06 Takeda Chem Ind Ltd 新規な固体分散体およびその製造方法
CN101022796B (zh) * 2004-07-14 2013-02-27 炎症研究中心有限公司 抑制肿瘤转移的方法
KR101086254B1 (ko) * 2004-11-04 2011-11-24 에스케이케미칼주식회사 생체이용률이 개선된 프란루카스트 고체분산체 조성물 및그 고체분산체의 제조방법
KR101233235B1 (ko) * 2005-08-26 2013-02-15 에스케이케미칼주식회사 초기 용출율이 개선된 프란루카스트 고체분산체의 약제학적조성물 및 그의 제조방법
JP4870402B2 (ja) * 2005-09-01 2012-02-08 小林化工株式会社 プランルカスト水和物含有錠の製造方法
KR100715355B1 (ko) 2005-09-30 2007-05-07 주식회사유한양행 프란루카스트를 함유하는 분무-건조 과립 및 그의 제조방법
KR100981751B1 (ko) * 2005-10-28 2010-09-10 주식회사유한양행 프란루카스트를 함유하는 과립 및 그의 제조방법
KR100981750B1 (ko) 2005-10-28 2010-09-10 주식회사유한양행 분무-건조 과립 및 그의 제조방법
WO2012091040A1 (ja) * 2010-12-27 2012-07-05 富田製薬株式会社 製剤用崩壊型核粒子
CN102178647B (zh) * 2011-04-28 2012-09-12 重庆圣华曦药物研究开发有限公司 普仑司特注射制剂
KR101378951B1 (ko) * 2011-07-29 2014-03-31 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 생체이용률이 향상된 초산 메게스트롤 분말을 포함하는 경구투여용 제제 및 이의 제조방법
CN103751108A (zh) * 2013-12-31 2014-04-30 北京万全德众医药生物技术有限公司 普仑司特固体分散体及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876760A (en) * 1995-06-12 1999-03-02 Ono Pharmaceutical Co., Ltd. Granules containing pranlukast, process for producing the granules, and method of improving adhesiveness of pranlukast
US6503537B2 (en) * 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
TW546151B (en) * 1997-07-23 2003-08-11 Senju Pharma Co Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative
US6224907B1 (en) * 1998-03-06 2001-05-01 Alza Corporation Anti-asthma therapy
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents

Also Published As

Publication number Publication date
CN1210065C (zh) 2005-07-13
US20030077322A1 (en) 2003-04-24
EP1283725B1 (en) 2006-07-19
JP2003534296A (ja) 2003-11-18
CA2405459A1 (en) 2001-11-29
KR20010106006A (ko) 2001-11-29
EP1283725A4 (en) 2003-06-25
WO2001089574A1 (en) 2001-11-29
DE60121574D1 (de) 2006-08-31
JP3967924B2 (ja) 2007-08-29
KR100381834B1 (ko) 2003-04-26
CN1430521A (zh) 2003-07-16
DE60121574T2 (de) 2007-06-21
EP1283725A1 (en) 2003-02-19

Similar Documents

Publication Publication Date Title
AU2513400A (en) Authentication system and process
AU2002213273A1 (en) Stenoprophiluric matrices, and methods of making and using the same
AU6629400A (en) Authentication system and method
AU3614901A (en) Polyorganosilsesquioxane and process for preparing the same
ZA200004485B (en) Sustained release microparticle and method for preparing the same.
MXPA01008882A (es) Metodo y sistema para el descubrimiento de cookies y otra informacion del cliente.
AU5194999A (en) Benzothiepin derivatives, process for the preparation of the same and uses thereof
AU4137601A (en) Methods, systems, and apparatuses for secure interactions
AU2001260727A1 (en) Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof
AU2001241068A1 (en) Indole derivatives, process for preparation of the same and use thereof
AU2856499A (en) Novel substances kf-1040t4a, kf-1040t4b, kf-1040t5a and kf-1040t5b and process for producing the same
AU2001278720A1 (en) Method of preparing publication, electronic publication using the method and displaying method therefor and network system
AU2002250858A1 (en) Capsule-in-capsule system and method for the production thereof
AU2001270292A1 (en) Structural biocomposite materials, systems, and methods
AU2002213227A1 (en) Generalizer system and method
AU2001260774A1 (en) Bio-support and preparing method of the same
AU3425700A (en) Non-ribosomal peptide synthetases, method for producing same and the use thereof
AU2001296604A1 (en) Simd system and method
AU2002233239A1 (en) Microparticles with an improved release profile and method for the production thereof
AU7446900A (en) Thioalkylamine derivatives and process for the preparation thereof
MXPA03003286A (es) Dispersion de pigmento y metodo para su preparacion.
PL354994A1 (en) Bio-supportive matrices, methods of making and using the same
AU6866500A (en) Chromone derivatives, process for the preparation of the same and uses thereof
AU2001261193A1 (en) Integrated security system and method
AU2002227966A1 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 16, NO 12, PAGE(S) 2688-2711 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 60727/01, 74288/01 AND 74687/01